Skin & hair

Squamous Cell Carcinoma — the Growing, Crusted Spot That Won't Heal

Save

Skin cancer can't be diagnosed by eye. Squamous cell carcinoma is a common skin cancer that grows from sun-damaged cells in the outer skin. This guide covers what it tends to look like, where it appears, what raises the risk, and how it's diagnosed — so you know which spots are worth photographing, tracking, and showing a clinician, and how soon.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

What does a squamous cell carcinoma look like?

A squamous cell carcinoma most often looks like a rough, scaly, or crusted patch, a firm pink or red bump, or an open sore that keeps growing and won't fully heal. Some build a raised, rolled border around a central dip; others form a hard, horn-like projection you can feel. They may be tender, itch, or bleed when knocked. Appearance alone never settles it, though — the same features can belong to a harmless growth, and a skin biopsy is what tells them apart and guides treatment 1.

The signal that matters more than any single feature is change over time. A spot that is enlarging week over week, that scabs and reopens in the same place, or that has newly become raised, tender, or bleeding is behaving in a way worth checking. A sore or scaly spot that keeps growing and hasn't healed within about a month deserves a clinician's eye, whatever it looked like at the start. A rough scaly spot that keeps growing is one of the most common ways an early squamous cell carcinoma first shows itself, which is exactly why it should be examined rather than watched indefinitely.

Squamous cell carcinomas also vary more than a single picture suggests. Some stay flat and scaly, like a stubborn patch of dry skin or a wart; others pile up into a raised nodule; a few grow a firm, keratin horn. On the lips they can look like a persistent chapped or white patch, and in an old wound they may simply be an ulcer that has stopped healing. That variety is the whole reason appearance alone is unreliable, and the reason clinicians biopsy rather than guess.

Where squamous cell carcinomas usually appear

Squamous cell carcinomas favor skin that has caught the most sun over a lifetime: the face, the tops and rims of the ears, the scalp where hair has thinned, the lower lip, the neck, the forearms, and the backs of the hands. In people who have spent years outdoors, the lower legs are common too. Because the underlying damage is cumulative, these tumors cluster where sunlight has landed most often and for the longest.

The lip and the ear deserve particular attention. A sore on the lip that won't heal — especially on the lower lip, which faces upward into the sun — can be a squamous cell carcinoma rather than a stubborn cold sore, and tumors on the lip and ear are treated as higher-risk partly because of where they sit 1. Squamous cell carcinoma can also arise where the sun never reaches: inside old burn scars, in chronic wounds and ulcers that don't close, and in areas of long-standing inflammation. A growing spot in one of those places deserves the same attention as one on sun-exposed skin, not less.

How is it different from a harmless scaly patch — or from other skin cancers?

Two growths commonly precede or resemble a squamous cell carcinoma. An actinic keratosis is a small, rough, sandpapery patch of sun-damaged skin, and a minority of these precancers can progress toward SCC — which is why clinicians tend to treat them rather than wait and watch. A basal cell carcinoma is a different, slower-growing skin cancer that more often looks like a pearly bump on the face that won't heal, with a translucent sheen and fine visible blood vessels; it is diagnosed by biopsy and usually treated with surgical excision or Mohs surgery 2.

A few less common look-alikes behave more aggressively and are worth naming. A fast-growing red-purple lump on the skin that appears over a few weeks can be a Merkel cell carcinoma, an uncommon but fast cancer. A firm nodule with a keratin-filled crater that enlarges quickly may need a biopsy to separate a squamous cell carcinoma from a keratoacanthoma. The through-line is the same across all of them: none can be sorted out by looking, and each is confirmed only under the microscope. That is the whole point of this page — it tells you which spots earn a closer look, not which spots are safe.

What actually raises the risk of squamous cell carcinoma?

The single largest driver is a lifetime of ultraviolet exposure. Avoiding UV radiation — from the sun, from sunlamps, and from tanning beds — is the main modifiable way to lower skin-cancer risk, because that damage accumulates in the skin's cells across decades 3. It is why squamous cell carcinoma clusters on the face, ears, scalp, and hands, and why it grows more common with age as exposure adds up.

Several other things raise the risk, or make a tumor higher-risk once it has formed. Fair skin that burns rather than tans, a history of many blistering sunburns, and prior radiation treatment all contribute. A suppressed immune system — after an organ transplant, or from immune-suppressing medication — raises squamous cell carcinoma risk substantially and makes tumors more likely to behave aggressively. Long-standing wounds, burn scars, and areas of chronic inflammation are further settings where SCC can develop. Features like these — together with a tumor's size and location — are what a clinician weighs when sorting a squamous cell carcinoma into the lower-risk or higher-risk group that decides how it is treated 1. In organ-transplant recipients especially, immunosuppression is treated as a high-risk feature, and those patients are often followed more closely because their tumors can be more numerous and behave more aggressively 1.

What to do about a spot you're worried about

No one can tell you from a photo or a paragraph whether your spot is a squamous cell carcinoma — a description cannot diagnose skin, and any page that claims otherwise is guessing. What you can do is give a clinician the two things that make the assessment easier: a clear record and a timeline. Photograph the spot in good light against a plain background, with something for scale beside it, and take the same photograph every few weeks so that any change is visible rather than remembered.

The rule of thumb is straightforward. A spot that keeps growing, a sore that won't heal within about a month, or a lesion that bleeds without a clear cause is worth having examined — not as an emergency in most cases, but within a few weeks rather than someday. If a spot changes fast — noticeably larger over a few weeks, newly painful, or bleeding repeatedly — that is a reason to move the appointment up rather than wait for a routine slot. Noting the date you first saw it, and roughly how big it was, gives the clinician a timeline a single photo can't. A store-and-forward teledermatology visit, where you send high-quality photographs for a clinician to review, can be one way to be seen sooner, and it works best when the images are sharp and well-lit 4. Photographs help the clinician triage; they don't replace the appointment, because the biopsy is still what decides.

How squamous cell carcinoma is diagnosed and treated

Diagnosis begins with a skin biopsy: a clinician removes a small sample so a pathologist can confirm the diagnosis under the microscope and describe how the cells are behaving. Treatment then follows the tumor's risk. Most low-risk squamous cell carcinomas are removed by standard surgical excision — cutting out the tumor with a margin of normal-looking skin around it — and the guideline sets the recommended margins for these low-risk tumors 1. If the pathology afterward shows the margins are not fully clear, a further excision may be needed to take the remaining edge, which is a routine part of confirming nothing was left behind 1.

Higher-risk tumors are handled differently. Mohs micrographic surgery removes the cancer in thin layers, each one checked under the microscope during the same visit until the margins read clear, which spares the most healthy tissue and is used for high-risk tumors and cosmetically sensitive sites 1. Appropriate-use criteria developed jointly by several societies map out which situations — aggressive patterns under the microscope, a tumor that has recurred, and high-risk anatomic locations such as the face, ears, and lips — make Mohs the appropriate choice 5. Radiation and other treatments have a role for tumors that cannot be operated on or in particular clinical situations, which is a conversation for the treating clinician rather than a decision made in advance.

Can squamous cell carcinoma be prevented or caught earlier?

Squamous cell carcinoma is one of the more preventable cancers, because its main driver is modifiable. Since avoiding ultraviolet radiation — daily sun, sunlamps, and tanning beds — is the main way to lower skin-cancer risk, the same habits that guard against sunburn protect against SCC over time: shade during peak hours, protective clothing and a wide-brimmed hat, and broad-spectrum sunscreen used consistently 3. None of this undoes past damage, but it slows the accumulation that drives new tumors.

Catching a tumor earlier is the other half of the work. Getting to know your own skin — including the scalp, ears, lips, and the backs of the hands, where these cancers concentrate — makes a new or changing spot easier to notice. Many people photograph the areas they can't see well, or ask someone to check their scalp and back. The goal is not to diagnose yourself; it is to notice change early enough that a clinician looks while the tumor is still small and the options are widest.

Is squamous cell carcinoma dangerous?

Squamous cell carcinoma is treated as a risk-stratified cancer for a reason: some tumors are low-risk and cured with a single straightforward removal, while a minority carry features that make them more likely to spread and so call for more aggressive treatment and closer follow-up. What pushes a tumor into the higher-risk group includes larger size, certain locations such as the lip and ear, recurrence after earlier treatment, aggressive patterns seen under the microscope, and a suppressed immune system 1. That is why a clinician stages and plans rather than treating every SCC the same way.

So the honest answer to whether squamous cell carcinoma is dangerous is that it depends — mostly on how early the tumor is found and which risk features it carries — and those are questions a biopsy and a clinician answer, not a description or a search result. The practical truth is that time works in your favor when a spot is examined early and against you when it is left for a year. If you have found yourself wondering whether your squamous cell carcinoma is dangerous, that wondering is itself the signal to book the visit, because the earlier a tumor is looked at, the more options remain on the table.

After a squamous cell carcinoma is removed, clinicians usually schedule periodic skin checks — both to watch the treated site and to look for new spots, since skin that has grown one sun-related cancer is the kind of sun-damaged skin that can grow others. What that schedule looks like depends on the tumor's risk features and is set by the treating clinician, not fixed in advance.

Common questions

It varies. Some enlarge slowly over months; others thicken or crater within weeks. The meaningful signal is not a fixed speed but the pattern: a spot that keeps growing, changing, or refusing to heal. A lesion behaving that way is worth having examined within a few weeks rather than waiting to see how fast it goes.

A true squamous cell carcinoma does not resolve by itself and tends to keep growing if left alone. One look-alike, a keratoacanthoma, can sometimes shrink, but it is confirmed only by biopsy and is often treated the same way. Because you cannot tell them apart by eye, a growing spot is not something to wait out.

Sometimes. A squamous cell carcinoma can be tender, itch, or feel like a sore spot that won't settle, but many are painless. Pain neither confirms nor rules it out. What counts more is whether the spot is growing, crusting, bleeding, or failing to heal — those features, not discomfort, are the reason to have it looked at.

An actinic keratosis is a rough, scaly precancerous patch of sun-damaged skin. A squamous cell carcinoma is an invasive cancer. A minority of actinic keratoses progress toward SCC over time, which is why clinicians often treat them early. Only a clinician's exam, and a biopsy where needed, can tell which stage a spot is at.

Sometimes teledermatology can help. Sending sharp, well-lit photographs to a clinician for review can triage a spot and move you toward care sooner. But if the lesion looks concerning, the next step is an in-person visit, because a biopsy — the only way to confirm skin cancer — has to be done in person.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When a skin spot needs a closer look

  • A sore or scab that has not healed within about a month, or that heals and then reopens in the same place
  • A rough or crusted spot that keeps enlarging, or a firm bump that grows over a few weeks
  • A lesion that bleeds when lightly bumped or without a clear cause
  • A new or changing growth on the lip, ear, or within an old scar, burn, or chronic wound

This article explains what a squamous cell carcinoma can look like and how it is evaluated. It cannot diagnose a spot on your skin — only an in-person clinician and a biopsy can do that. Use it to decide what is worth showing a clinician, not to rule a spot in or out.

References

  1. 1.Kim JYS, Kozlow JH, Mittal B, et al. (2018). Guidelines of care for the management of cutaneous squamous cell carcinoma. Journal of the American Academy of Dermatology. doi:10.1016/j.jaad.2017.10.007AAD guideline that cutaneous SCC is diagnosed by biopsy and then managed by risk stratification, with standard surgical excision at recommended margins for low-risk tumors and Mohs micrographic surgery for high-risk tumors; higher-risk features include tumor size, high-risk locations such as the lip and ear, recurrence, aggressive histology, and immunosuppression.
  2. 2.Kim JYS, Kozlow JH, Mittal B, et al. (2018). Guidelines of care for the management of basal cell carcinoma. Journal of the American Academy of Dermatology. doi:10.1016/j.jaad.2017.10.006AAD guideline that basal cell carcinoma is diagnosed by biopsy and typically treated with surgical excision, with Mohs micrographic surgery reserved for high-risk and facial tumors.
  3. 3.National Cancer Institute (PDQ Screening and Prevention Editorial Board) (2025). Skin Cancer Prevention (PDQ®)–Health Professional Version. NIH / National Cancer Institute. linkNCI PDQ evidence that avoiding UV radiation from the sun, sunlamps, and tanning beds is the main modifiable way to reduce skin-cancer risk.
  4. 4.American Academy of Dermatology (2024). Teledermatology Standards. American Academy of Dermatology. linkAAD teledermatology standards describing how store-and-forward teledermatology is delivered and that it depends on high-quality, well-lit images.
  5. 5.Ad Hoc Task Force (Connolly SM, Baker DR, Coldiron BM, et al.) (2012). AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery. Journal of the American Academy of Dermatology. doi:10.1016/j.jaad.2012.06.009Multi-society appropriate use criteria identifying aggressive histology, recurrent tumors, and high-risk anatomic locations as scenarios where Mohs micrographic surgery is appropriate.

5 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy